Wnt-beta-catenin pathway inhibitors (BetaCat Pharmaceuticals)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameWnt-beta-catenin pathway inhibitors (BetaCat Pharmaceuticals)
Drug Alias NameBC-3000
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCatenin beta 1 degraders
TargetsCatenin beta 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIterion Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIterion Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A